Long-term Follow-up of Adults With Crohn Disease and Ulcerative Colitis in Germany
Collects routine-care information on adults with inflammatory bowel disease across Germany.
Key facts
- Who runs it
- ImmunoRegister gUG
- Where
- Hamburg, GermanySee the site
- Trial code
- Registry title
- CEDUR - German IBD Registry
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 3 May 2018
- Expected to end
- May 2036
- Type of study
- Observational
- Record updated
- 6 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with inflammatory bowel disease: Crohn disease, ulcerative colitis or indeterminate colitis. It follows them over time in routine care in Germany.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Crohn disease, ulcerative colitis or indeterminate colitis. No stage or severity is named.
Main reasons for not taking part
- Other bowel or digestive disorders than the three named above
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Crohn Disease Ulcerative Colitis Indterminate Colitis
Who cannot take part
- Other gastrointestinal disorders than above
Where in Germany
- ImmunoRegister gUGHamburg, GermanyContact: Stefanie Howaldt, MDTaking people
About the trial
What the trial wants to find out
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"
- Plain-language title
- Long-term Follow-up of Adults With Crohn Disease and Ulcerative Colitis in GermanyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 6 January 2026